{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:26Z","timestamp":1792782746691,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T00:00:00Z","timestamp":1446854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"none","award":["none"],"award-info":[{"award-number":["none"]}]},{"name":"none","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00520-015-3009-x","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T19:28:36Z","timestamp":1446838116000},"page":"2085-2091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case\u2013control study"],"prefix":"10.1007","volume":"24","author":[{"given":"Tulay","family":"Kus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokmen","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokay","family":"Alpak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Emin","family":"Kalender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Sevinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seval","family":"Kul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"Temizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celaletdin","family":"Camci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,7]]},"reference":[{"key":"3009_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpain.2011.11.009","volume":"13","author":"L Cesare Mannelli Di","year":"2012","unstructured":"Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C (2012) Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J Pain 13:276\u2013284","journal-title":"J Pain"},{"key":"3009_CR2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1152\/jn.2001.85.5.2293","volume":"85","author":"F Grolleau","year":"2001","unstructured":"Grolleau F, Gamelin L, Boisdron-Celle M, Lapied B, Pelhate M, Gamelin E (2001) A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 85:2293\u20132297","journal-title":"J Neurophysiol"},{"key":"3009_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/BF02968008","volume":"11","author":"H Hagiwara","year":"2004","unstructured":"Hagiwara H, Sunada Y (2004) Mechanism of taxane neurotoxicity. Breast Cancer 11:82\u201385","journal-title":"Breast Cancer"},{"key":"3009_CR4","first-page":"1","volume":"20","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered by paclitaxel. Semin Oncol 20:1\u201315","journal-title":"Semin Oncol"},{"key":"3009_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1592\/phco.24.6.621.34748","volume":"24","author":"DR Grothe","year":"2004","unstructured":"Grothe DR, Scheckner B, Albano D (2004) Treatment of pain syndromes with venlafaxine. Pharmacotherapy 24:621\u2013629","journal-title":"Pharmacotherapy"},{"key":"3009_CR6","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.2337\/diacare.22.11.1909","volume":"22","author":"JL Davis","year":"1999","unstructured":"Davis JL, Smith RL (1999) Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care 22:1909\u20131910","journal-title":"Diabetes Care"},{"key":"3009_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","volume":"108","author":"D Bouhassira","year":"2004","unstructured":"Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F (2004) Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108:248\u2013257","journal-title":"Pain"},{"key":"3009_CR8","first-page":"2601","volume":"29","author":"AL Kautio","year":"2009","unstructured":"Kautio AL, Haanpaa M, Leminen A, Kalso E, Kautiainen H, Saarto T (2009) Amitriptyline in the prevention of chemotherapy induced neuropathic symptoms. Anticancer Res 29:2601\u20132606","journal-title":"Anticancer Res"},{"key":"3009_CR9","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/cncr.23008","volume":"110","author":"RD Rao","year":"2007","unstructured":"Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA, Wong GY, North Central Cancer Treatment Group (2007) Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 110:2110\u20132118","journal-title":"Cancer"},{"key":"3009_CR10","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1002\/cncr.23482","volume":"112","author":"RD Rao","year":"2008","unstructured":"Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL (2008) Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 112:2802\u20132808","journal-title":"Cancer"},{"key":"3009_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1590\/S1516-31802013000100006","volume":"131","author":"SO Afonseca","year":"2013","unstructured":"Afonseca SO, Cruz FM, Cubero Dde I, Lera AT, Schindler F, Okawara M, Souza LF, Rodrigues NP, Giglio AD (2013) Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial. Sao Paulo Med J 131:35\u201338","journal-title":"Sao Paulo Med J"},{"issue":"10","key":"3009_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1200\/JCO.2013.52.0536","volume":"32","author":"CL Loprinzi","year":"2014","unstructured":"Loprinzi CL, Qin R, Dakhil SR, Fehrenbacher L, Flynn KA, Atherton P, Seisler D, Qamar R, Lewis GC, Grothey A (2014) Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB\/Alliance). J Clin Oncol 32(10):997\u20131005","journal-title":"J Clin Oncol"},{"key":"3009_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1200\/JCO.2010.31.5911","volume":"29","author":"A Grothey","year":"2011","unstructured":"Grothey A, Nikcevich DA, Sloan JA, Kugler JW, Silberstein PT, Dentchev T, Wender DB, Novotny PJ, Chitaley U, Alberts SR, Loprinzi CL (2011) Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol 29:421\u2013427","journal-title":"J Clin Oncol"},{"key":"3009_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1471-2407-12-355","volume":"12","author":"Z Ghoreishi","year":"2012","unstructured":"Ghoreishi Z, Esfahani A, Djazayeri A, Djalali M, Golestan B, Ayromlou H, Hashemzade S, Asghari Jafarabadi M, Montazeri V, Keshavarz SA, Darabi M (2012) Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial. BMC Cancer 12:355","journal-title":"BMC Cancer"},{"key":"3009_CR15","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EM Smith","year":"2013","unstructured":"Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL (2013) Alliance for Clinical Trials in Oncology Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309:1359\u20131367","journal-title":"JAMA"},{"key":"3009_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/annonc\/mdr045","volume":"23","author":"JP Durand","year":"2012","unstructured":"Durand JP, Deplanque G, Montheil V, Gornet JM, Scotte F, Mir O, Cessot A, Coriat R, Raymond E, Mitry E, Herait P, Yataghene Y, Goldwasser F (2012) Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 23:200\u2013205","journal-title":"Ann Oncol"},{"key":"3009_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000345035","volume":"91","author":"K Cegielska-Perun","year":"2013","unstructured":"Cegielska-Perun K, Bujalska-Zadro\u017cny M, Tatarkiewicz J, G\u0105si\u0144ska E, Makulska-Nowak HE (2013) Venlafaxine and neuropathic pain. Pharmacology 91:69\u201376","journal-title":"Pharmacology"},{"key":"3009_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.pnpbp.2008.11.010","volume":"33","author":"A Zafir","year":"2009","unstructured":"Zafir A, Ara A, Banu N (2009) In vivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 33:220\u2013228","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3009_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/FPC.0b013e3283335277","volume":"19","author":"C Oshiro","year":"2009","unstructured":"Oshiro C, Marsh S, McLeod H, Carrillo MW, Klein T, Altman R (2009) Taxane pathway. Pharmacogenet Genomics 19:979\u2013983","journal-title":"Pharmacogenet Genomics"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-3009-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-3009-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-3009-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-3009-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T05:50:38Z","timestamp":1567317038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-3009-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,7]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3009"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-3009-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,7]]}}}